Biotrin opens sales office in US:
This article was originally published in Clinica
Irish diagnostics company Biotrin has opened its first sales office in the US. Located in Boston, Massachusetts, the office will enable the Dublin-based company to target its research industry customers on the East coast more effectively. Although Biotrin's most important products are still in development, it recorded sales of I£2.5 million ($3.7 million) in 1997.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.
How do notified bodies ensure that their personnel, and the teams they allocate for conformity assessment of medical devices, have the precise knowledge and expertise needed? A new EU document gives guidance on this.